Report Detail
Infusion Pumps and Accessories Global Market - Forecast to 2026
- RnM3855617 |
- 12 March, 2020 |
- Global |
- 544 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
Infusion pumps and accessories are class of drug delivering devices used for administering medications in a controlled, precise and automated manner. These devices are mainly used for therapeutic purposes in critical care, pain management and other applications, where continuous medication is required to make patient feel comfortable and pain-free. These infusion systems help in avoiding medical errors which would lead to serious life-threatening circumstances or even sometimes to death of a patient. According to IQ4I analysis, the infusion pumps and accessories global market is expected to reach $13,867.0 million by 2026 growing at a mid single digit CAGR from 2019 to 2026.
Infusion pumps and accessories market is segmented on the basis of products, applications, mode of administration, end-users and geography. The infusion pumps and accessories products market is segmented into infusion pumps, consumables, software and servicing, among them infusion pumps held the largest share in 2019 and are expected to grow at a mid single digit CAGR of from 2019 to 2026. Infusion pumps are further sub-segmented into external infusion pumps and implantable infusion pumps. The external infusion pump accounted for the largest share of in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026. External infusion pumps are further segmented into volumetric infusion pumps, syringe infusion pumps, ambulatory Infusion pumps, disposable infusion pumps, enteral infusion pump and insulin infusion pumps. Among external infusion pumps, insulin infusion pump accounted for the largest share and is expected to grow at a high single digit CAGR from 2019 to 2026. Consumables are segmented into infusion catheters, infusion sets, cannula, valves and others; the infusion catheters segment accounted for the largest share in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026. Applications are segmented into chemotherapy, gastroenterology, pain management, diabetes, hematology, total parenteral nutrition, antibiotics, IVIg/specialty pharmaceuticals and others. Among them, the diabetes segment held the largest share in 2019 and is expected to be the fastest growing segment with a mid single digit CAGR from 2019 to 2026.
The mode of administration market is segmented into intravenous, subcutaneous, epidural, Intra-arterial, enteral and others. In this segment subcutaneous mode of administration accounted for the largest share in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026. End-users are classified into hospitals, ambulatory surgical centers, homecare and others. Among them, hospitals commanded the largest segmental share in 2019 and homecare is expected to be the fastest growing segment with a mid single digit CAGR from 2019 to 2026. Hospitals are further segmented into general ward, emergency, critical care and acute care. General ward commanded the largest share in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026.
Geographically, North America is the largest share followed by Europe and Asia Pacific. The APAC region is the fastest growing region and is expected to grow at a mid single digit CAGR from 2019 to 2026 presenting an array of opportunities for growth and is likely to get the attention of new investors in the infusion pumps and accessories market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The infusion pumps and accessories market is expected to grow steadily at a mid single digit CAGR from 2019 to 2026. Increase in aging population and subsequent rise in incidence of chronic diseases, technological innovations offering wider scope of applications for infusion pumps and increase in use of infusion products in home care setting are the factors driving the market growth. The increasing trend for wireless infusion pumps, emergence of smart pumps and market expansion in emerging nations are expected to offer potential opportunities.
However, various factors such as patient safety risks and medication errors associated with infusion pumps, increasing number of infusion pump product recalls are limiting the growth of infusion pumps and accessories global market. The threats for the infusion pumps and accessories market include lack of cyber-security in wireless infusion pumps and stringent regulatory requirements for new products
The infusion pumps and accessories global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the infusion pumps and accessories market are Baxter International, Inc. (U.S.) and B. Braun Melsungen AG (Germany), Becton Dickinson & Company (U.S.), Cardinal Health Inc. (U.S.), Fresenius SE & Co. (Germany), ICU Medical Inc. (U.S.), Insulet Corporation (U.S.), Medtronic PLC (Ireland), Nestle Group (Switzerland), Smiths Group PLC (U.K.), Tandem Diabetes Care Inc. (U.S.) and Terumo Corporation (Japan).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Rest of North America
• Europe
o Germany
o France
o U.K.
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Rest of APAC
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East and Others
1 EXECUTIVE SUMMARY 32
2 INTRODUCTION 37
- 2.1 KEY TAKEAWAYS 37
- 2.2 SCOPE OF THE REPORT 38
- 2.3 REPORT DESCRIPTION 38
- 2.4 MARKETS COVERED 40
- 2.5 STAKEHOLDERS 42
- 2.6 RESEARCH METHODOLOGY 43
- 2.6.1 MARKET SIZE ESTIMATION 44
- 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 47
- 2.6.3 SECONDARY SOURCES 48
- 2.6.4 PRIMARY SOURCES 48
- 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 49
- 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 50
- 2.6.7 ASSUMPTIONS 50
3 MARKET ANALYSIS 53
- 3.1 INTRODUCTION 53
- 3.2 MARKET SEGMENTATION 54
- 3.3 FACTORS INFLUENCING MARKET 56
- 3.3.1 DRIVERS AND OPPORTUNITIES 56
- 3.3.1.1 Increase in aging population and subsequent risein the incidence of chronic diseases 56
- 3.3.1.2 Technological advancements offering a wider scope of applications for infusion pumps 57
- 3.3.1.3 Increasing use of infusion pumps in-home care settings 58
- 3.3.1.4 Market expansion opportunities in emerging nations 58
- 3.3.1.5 Increase in hospitalization 59
- 3.3.2 RESTRAINTS AND THREATS 60
- 3.3.2.1 Patient safety risks and medication errors associated with infusion pumps 60
- 3.3.2.2 Increasing number of infusion pump product recalls. 61
- 3.3.2.3 Lack of cyber security in wireless infusion pumps 61
- 3.3.2.4 Stringent regulatory requirements for new products 62
- 3.3.1 DRIVERS AND OPPORTUNITIES 56
- 3.4 REGULATORY AFFAIRS 63
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 64
- 3.4.1.1 ISO 9001: 2015 quality management system 64
- 3.4.1.2 ISO 13485 medical devices 64
- 3.4.2 U.S. 65
- 3.4.3 CANADA 65
- 3.4.4 EUROPE 66
- 3.4.5 INDIA 67
- 3.4.6 CHINA 68
- 3.4.7 JAPAN 69
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 64
- 3.5 REIMBURSEMENT SCENARIO 70
- 3.6 CPT CODES 70
- 3.7 PATENT TRENDS 76
- 3.8 TECHNOLOGICAL ADVANCEMENTS 77
- 3.8.1 INTRODUCTION 77
- 3.8.2 NEXT GENERATION OF BARCODE ASSISTED INFUSION (BAI): 77
- 3.8.3 INTELLIGENT INTRAVENOUS INFUSION PUMP 78
- 3.8.4 MECHATRONIC SYRINGE PUMP 79
- 3.8.5 INFUSION TELE-THERAPY IN HOME 79
- 3.9 CLINICAL TRIALS 80
- 3.10 PRODUCT RECALLS 86
- 3.11 PORTER’S FIVE FORCE ANALYSIS 91
- 3.11.1 THREAT OF NEW ENTRANTS 92
- 3.11.2 THREAT OF SUBSTITUTES 92
- 3.11.3 RIVALRY AMONG EXISTING COMPETITORS 93
- 3.11.4 BARGAINING POWER OF SUPPLIERS 93
- 3.11.5 BARGAINING POWER OF BUYERS 94
- 3.12 SUPPLY CHAIN ANALYSIS 94
- 3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 98
- 3.13.1 INFUSION PUMPS AND ACCESSORIES GLOBAL MARKET
SHARE ANALYSIS 98
- 3.13.2 VOLUMETRIC INFUSION PUMPS MARKET SHARE ANALYSIS 102
- 3.13.3 SYRINGE INFUSION PUMPS MARKET SHARE ANALYSIS 105
- 3.13.4 AMBULATORY INFUSION PUMPS MARKET SHARE ANALYSIS 107
- 3.13.5 DISPOSABLE INFUSION PUMPS MARKET SHARE ANALYSIS 109
- 3.13.6 ENTERAL INFUSION PUMPS MARKET SHARE ANALYSIS 112
- 3.13.7 INSULIN INFUSION PUMPS MARKET SHARE ANALYSIS 114
- 3.13.8 IMPLANTABLE INFUSION PUMPS MARKET SHARE ANALYSIS 116
4 INFUSION PUMPS AND ACCESSORIES GLOBAL MARKET, BY PRODUCTS 151
- 4.1 INTRODUCTION 151
- 4.2 INFUSION PUMPS 153
- 4.2.1 EXTERNAL INFUSION PUMPS 158
- 4.2.1.1 Volumetric infusion pumps 161
- 4.2.1.2 Syringe infusion pumps 164
- 4.2.1.3 Ambulatory infusion pumps 168
- 4.2.1.4 Disposable infusion pumps 170
- 4.2.1.4.1 Elastomeric infusion pump 175
- 4.2.1.4.2 Patient-controlled analgesia pumps 177
- 4.2.1.5 Enteral infusion pumps 180
- 4.2.1.6 Insulin infusion pumps 182
- 4.2.2 IMPLANTABLE INFUSION PUMPS 184
- 4.2.1 EXTERNAL INFUSION PUMPS 158
- 4.3 CONSUMABLES 187
- 4.3.1 INFUSION CATHETERS 191
- 4.3.2 INFUSION SETS 193
- 4.3.3 CANNULA 195
- 4.3.4 VALVES 197
- 4.3.5 OTHERS 199
- 4.4 SOFTWARE AND SERVICES 200
5 INFUSION PUMPS AND ACCESSORIES GLOBAL MARKET, BY APPLICATION 204
- 5.1 INTRODUCTION 204
- 5.2 CHEMOTHERAPY 209
- 5.3 GASTROENTEROLOGY 211
- 5.4 PAIN MANAGEMENT 214
- 5.5 DIABETES 217
- 5.6 HEMATOLOGY 219
- 5.7 TOTAL PARENTERAL NUTRITION 222
- 5.8 ANTIBIOTICS 225
- 5.9 IVIG/SPECIALITY PHARMACEUTICALS 227
- 5.10 OTHERS 229
6 INFUSION PUMPS AND ACCESSORIES GLOBAL MARKET, BY MODE OF ADMINISTRATION 232
- 6.1 INTRODUCTION 232
- 6.2 INTRAVENOUS 236
- 6.3 SUBCUTANEOUS 238
- 6.4 EPIDURAL 241
- 6.5 INTRA-ARTERIAL 243
- 6.6 ENTERAL 245
- 6.7 OTHERS 247
7 INFUSION PUMPS AND ACCESSORIES GLOBAL MARKET, BY END-USERS 249
- 7.1 INTRODUCTION 249
- 7.2 HOSPITALS 252
- 7.2.1 EMERGENCY CARE 256
- 7.2.2 CRITICAL CARE 258
- 7.2.3 ACUTE CARE 259
- 7.2.4 GENERAL WARD 261
- 7.3 AMBULATORY SURGICAL CENTERS 262
- 7.4 HOME HEALTHCARE 264
- 7.5 OTHERS 266
8 REGIONAL MARKET ANALYSIS 269
- 8.1 INTRODUCTION 269
- 8.2 NORTH AMERICA 273
- 8.2.1 U.S. 295
- 8.2.2 REST OF NORTH AMERICA 302
- 8.3 EUROPE 309
- 8.3.1 GERMANY 331
- 8.3.2 FRANCE 337
- 8.3.3 U.K. 342
- 8.3.4 REST OF EUROPE 349
- 8.4 APAC 355
- 8.4.1 JAPAN 377
- 8.4.2 CHINA 383
- 8.4.3 INDIA 389
- 8.4.4 REST OF APAC 395
- 8.5 REST OF THE WORLD 401
- 8.5.1 BRAZIL 422
- 8.5.2 REST OF LATIN AMERICA 428
- 8.5.3 MIDDLE EAST AND OTHERS 434
9 COMPETITIVE LANDSCAPE 440
- 9.1 INTRODUCTION 440
- 9.1.1 APPROVALS AS A MAJOR GROWTH STRATEGY OF INFUSION PUMPS
AND ACCESSORIES MARKET PLAYERS 441
- 9.2 APPROVAL 441
- 9.3 AGREEMENTS, PARTERNERSHIPS AND COLLABORATIONS 445
- 9.4 NEW PRODUCT LAUNCH 448
- 9.5 OTHERS 449
10 MAJOR COMPANIES 454
- 10.1 B. BRAUN MELSUNGEN AG 454
- 10.1.1 OVERVIEW 454
- 10.1.2 FINANCIALS 455
- 10.1.3 PRODUCT PORTFOLIO 458
- 10.1.4 KEY DEVELOPMENTS 459
- 10.1.5 BUSINESS STRATEGY 461
- 10.1.6 SWOT ANALYSIS 462
- 10.2 BAXTER INTERNATIONAL, INC. 463
- 10.2.1 OVERVIEW 463
- 10.2.2 FINANCIALS 464
- 10.2.3 PRODUCT PORTFOLIO 466
- 10.2.4 KEY DEVELOPMENTS 467
- 10.2.5 BUSINESS STRATEGY 468
- 10.2.6 SWOT ANALYSIS 469
- 10.3 BECTON DICKINSON AND COMPANY 470
- 10.3.1 OVERVIEW 470
- 10.3.2 FINANCIALS 471
- 10.3.3 PRODUCT PORTFOLIO 474
- 10.3.4 KEY DEVELOPMENTS 475
- 10.3.5 BUSINESS STRATEGY 476
- 10.3.6 SWOT ANALYSIS 476
- 10.4 CARDINAL HEALTH, INC. 477
- 10.4.1 OVERVIEW 477
- 10.4.2 FINANCIALS 478
- 10.4.3 PRODUCT PORTFOLIO 480
- 10.4.4 KEY DEVELOPMENTS 480
- 10.4.5 BUSINESS STRATEGY 481
- 10.4.6 SWOT ANALYSIS 482
- 10.5 FRASENIUS S.E. & CO (FRASENIUS KABI) 483
- 10.5.1 OVERVIEW 483
- 10.5.2 FINANCIALS 484
- 10.5.3 PRODUCT PORTFOLIO 487
- 10.5.4 KEY DEVELOPMENTS 488
- 10.5.5 BUSINESS STRATEGY 489
- 10.5.6 SWOT ANALYSIS 489
- 10.6 ICU MEDICALS, INC. 490
- 10.6.1 OVERVIEW 490
- 10.6.2 FINANCIALS 491
- 10.6.3 PRODUCT PORTFOLIO 493
- 10.6.4 KEY DEVELOPMENTS 494
- 10.6.5 BUSINESS STRATEGY 496
- 10.6.6 SWOT ANALYSIS 497
- 10.7 INSULET CORPORATION 498
- 10.7.1 OVERVIEW 498
- 10.7.2 FINANCIALS 499
- 10.7.3 PRODUCT PORTFOLIO 501
- 10.7.4 KEY DEVELOPMENTS 502
- 10.7.5 BUSINESS STRATEGY 503
- 10.7.6 SWOT ANALYSIS 504
- 10.8 MEDTRONIC PLC 505
- 10.8.1 OVERVIEW 505
- 10.8.2 FINANCIALS 506
- 10.8.3 PRODUCT PORTFOLIO 508
- 10.8.4 KEY DEVELOPMENTS 510
- 10.8.5 BUSINESS STRATEGY 512
- 10.8.6 SWOT ANALYSIS 513
- 10.9 NESTLE S.A. 514
- 10.9.1 OVERVIEW 514
- 10.9.2 FINANCIALS 515
- 10.9.3 PRODUCT PORTFOLIO 517
- 10.9.4 KEY DEVELOPMENTS 518
- 10.9.5 BUSINESS STRATEGY 518
- 10.9.6 SWOT ANALYSIS 519
- 10.10 SMITHS MEDICALS (SMITHS GROUP PLC ) 520
- 10.10.1 OVERVIEW 520
- 10.10.2 FINANCIALS 521
- 10.10.3 PRODUCT PORTFOLIO 524
- 10.10.4 KEY DEVELOPMENTS 527
- 10.10.5 BUSINESS STRATEGY 528
- 10.10.6 SWOT ANALYSIS 529
- 10.11 TANDEM DIABETES CARE INC. 530
- 10.11.1 OVERVIEW 530
- 10.11.2 FINANCIALS 531
- 10.11.3 PRODUCT PORTFOLIO 534
- 10.11.4 KEY DEVELOPMENTS 534
- 10.11.5 BUSINESS STRATEGY 536
- 10.11.6 SWOT ANALYSIS 537
- 10.12 TERUMO CORPORATION 538
- 10.12.1 OVERVIEW 538
- 10.12.2 FINANCIALS 539
- 10.12.3 PRODUCT PORTFOLIO 541
- 10.12.4 KEY DEVELOPMENTS 542
- 10.12.5 BUSINESS STRATEGY 542
Summary:
Get latest Market Research Reports on Infusion Pumps and Accessories. Industry analysis & Market Report on Infusion Pumps and Accessories is a syndicated market report, published as Infusion Pumps and Accessories Global Market - Forecast to 2026. It is complete Research Study and Industry Analysis of Infusion Pumps and Accessories market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
